#Epro ontime series
The oversized tunnel, large enough for race team haulers, fans’ recreational vehicles, and massive track tram vehicles to enter and exit the track simultaneously, was fast-tracked to allow for completion by April 27-28, 2019 when the GEICO 500, a Monster Energy NASCAR Cup Series Race, takes place. Studies a U.S.WICHITA, KS… Products by EPRO Services, Inc., an innovator of composite waterproofing, methane mitigation, and vapor intrusion systems, were specified to protect an integral tunnel within the Talladega Superspeedway’s $50 million overall redevelopment project. Publications will be made in accordance with the established criteria for publication of the research results, which can be found in the study protocol, as well as in accordance with national data protection guidelines and internationally applicable provisions of the basic data protection regulation.
The analyses will be conducted until the end of the project. The study protocol will be published in a scientific journal. The research results will only be published in anonymized form and after statistical and qualitative evaluation.
In addition, it is sensitive data derived from a vulnerable patient group, i.e. The research data will not be published as no consent has been obtained for this. Individual Participant Data (IPD) Sharing Statement:
#Epro ontime trial
U1111-1251-0043 ( Registry Identifier: Universal Trial Number (WHO) ) Layout table for additonal informationĬentre for Research and Technology HellasĭRKS00021458 ( Registry Identifier: German Clinical Trials Register )Ĩ25872 ( Other Grant/Funding Number: Horizon 2020 Grant Agreement Number ) MyPal-Child study protocol: an observational prospective clinical feasibility study of the MyPal ePRO-based early palliative care digital system in paediatric oncology patients. Meyerheim M, Karamanidou C, Payne S, Garani-Papadatos T, Sander A, Downing J, Stamatopoulos K, Ling J, Payne C, Scarfò L, Lokaj P, Maramis C, Graf N. This judgment has to be documented for each parent not being enrolled. Anyone who is not able to participate in the study according to the clinical judgment of the site chief investigator or any other authorized person of the research team.This judgment has to be documented for each child not being enrolled. These documents had been evaluated positively by IEC. Provide signed informed consent by parent(s).Ability to speak, read and understand German or Czech language.Parent(s) with a child eligible for the study, as per the inclusion and exclusion-criteria.Access to an internet connection and mobile device (e.g.Provide signed + informed consent from parents or legal representative and the assent form by all children from the age of 14 years.Have age-appropriate speaking, reading and comprehension skills in either the German or the Czech language.Receiving anti-cancer treatment at one of the participating clinical site.